DMK PHARMACEUTICALS Corp Quarterly Interest Expense in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
DMK PHARMACEUTICALS Corp quarterly/annual Interest Expense history and growth rate from Q2 2010 to Q3 2023.
  • DMK PHARMACEUTICALS Corp Interest Expense for the quarter ending September 30, 2023 was $29.5K.
  • DMK PHARMACEUTICALS Corp annual Interest Expense for 2021 was $6.65K, a 35.1% increase from 2020.
  • DMK PHARMACEUTICALS Corp annual Interest Expense for 2020 was $4.92K, a 96% decline from 2019.
  • DMK PHARMACEUTICALS Corp annual Interest Expense for 2019 was $123K, a 21.9% decline from 2018.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $29.5K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $46.3K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-21
Q4 2021 $6.65K $0 +$68K Oct 1, 2021 Dec 31, 2021 10-K 2022-03-31
Q3 2021 -$61.4K $1.87K +$143 +8.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$61.5K $2.9K -$30K -91.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$31.5K $1.88K -$36.4K -95.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $4.92K -$68K -$122K -225% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $127K $1.72K -$20.2K -92.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 $148K $32.9K +$9.97K +43.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-22
Q1 2020 $138K $38.3K +$14.3K +59.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-22
Q4 2019 $123K $54.4K +$29.4K +117% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 $93.9K $21.9K -$8.72K -28.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $103K $23K -$28.5K -55.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-17
Q1 2019 $131K $24K -$26.7K -52.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-18
Q4 2018 $158K $25K -$26.7K -51.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 $185K $30.7K -$22K -41.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $206K $51.4K -$8K -13.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $214K $50.7K -$16.8K -24.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $231K $51.8K Oct 1, 2017 Dec 31, 2017 10-K 2019-03-15
Q3 2017 $52.6K -$17.6K -25.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $59.4K -$13K -17.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $67.5K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q3 2016 $70.2K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $72.4K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q2 2014 $8.45M $226K -$179K -44.2% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $8.63M $145K -$469K -76.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 $9.1M $5.3M +$4.45M +527% Oct 1, 2013 Dec 31, 2013 10-Q 2014-02-14
Q3 2013 $4.64M $2.78M +$2.2M +379% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-14
Q2 2013 $2.44M $405K +$110K +37.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $2.33M $615K +$612K +22512% Jan 1, 2013 Mar 31, 2013 10-K 2014-06-23
Q4 2012 $1.72M $845K +$842K +32242% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-14
Q3 2012 $880K $579K +$577K +22601% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 $303K $295K +$267K +972% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-19
Q1 2012 $35.4K $2.72K -$28.9K -91.4% Jan 1, 2012 Mar 31, 2012 10-K 2013-07-03
Q4 2011 $64.2K $2.61K -$69.5K -96.4% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
Q3 2011 $134K $2.55K -$316K -99.2% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-13
Q2 2011 $450K $27.5K -$295K -91.5% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-17
Q1 2011 $744K $31.6K Jan 1, 2011 Mar 31, 2011 10-K 2012-06-29
Q4 2010 $72.1K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 $318K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 $322K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.